Sanofi_EFC18326_Phase 3 Anti-TL1A IBD Program - Crohn's Dx Pro00119061
Clinical Trial Grant
Administered By
Medicine, Gastroenterology
Awarded By
Sanofi US
Start Date
January 6, 2026
End Date
June 30, 2030
Administered By
Medicine, Gastroenterology
Awarded By
Sanofi US
Start Date
January 6, 2026
End Date
June 30, 2030